Full Name
Deborah Korenstein, MD
Job Title
Chief of Internal Medicine Service
Memorial Sloan Kettering Cancer Center
Speaker Bio
Deborah Korenstein MD, FACP is a general internist, educator, and health services researcher. She is Director of Clinical Effectiveness at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and Chief of the General Medicine Service, as well as a Professor of Medicine at Weill Cornell Medical College. She earned a BA in Mathematics from the University of Pennsylvania and her MD from Columbia University’s College of Physicians & Surgeons and completed internship and residency in internal medicine at Beth Israel Hospital in Boston. Her main research and educational efforts focus on avoiding overuse of medical resources and optimizing care value; other areas of interest include evidence-based medicine (EBM), determinants of high drug prices, and optimal management of conflicts of interest (COI) in medical education, research, and practice. Prior to her role at MSKCC, Dr. Korenstein was an Associate Program Director in Internal Medicine, the founding Director of the Primary Care Residency Program, and Director of Education for the Division of General Internal Medicine at the Icahn School of Medicine at Mount Sinai. She also served as Editor-in-Chief of ACP Smart Medicine, an evidence-based clinical decision support tool and was a member and Chair of the EBM Task Force of the Society of General Internal Medicine (SGIM) and a member of SGIM’s Choosing Wisely Ad Hoc Committee. As an educator, Dr. Korenstein has taught extensively through both lectures and small-group activities and has developed curricula for all medical educational levels (UME, GME, and CME), mainly related to COI, EBM, and optimizing care value. As a researcher, she has performed educational and health services research, including multiple systematic reviews/meta-analyses on medical overuse and other topics. Current work encompasses research to understand factors that lead to patients’ receipt of unnecessary care, the impact of COI on prescribing and drug prices, attitudes toward and use of opioids and cannabinoids in cancer patients and survivors.

Dr. Korenstein provides clinical care as a general internist to adults who are long-term survivors of childhood cancer and to patients undergoing active cancer treatment.
Deborah Korenstein, MD